Samiul Muquit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Samiul Muquit has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Shahzad
Southwest Neurosurgical Centre, University Hospitals Plymouth NHS Trust, Plymouth, UK.
3 shared publications - Mohammad Ashraf
Wolfson School of Medicine, University of Glasgow, Scotland, UK
2 shared publications - Aditya Shivane
Department of Pathology, University Hospitals Plymouth NHS Trust, Plymouth, England, United Kingdom
1 shared publication Agbolahan Sofela
Department of Neurosurgery, Southwest Neurosurgery Centre, University Hospitals Plymouth NHS Trust, Plymouth, UK
1 shared publication- Amy Ronaldson
King’s College London
1 shared publication Arif Janjua
University of British Columbia
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5560
Exogenous Hormones and Their Clinical Implications for the Development and Growth of Meningioma Tumours
Meningiomas are the most common central nervous system tumour and are associated with significant morbidity. Mounting evidence implicates the role of exogenous hormones in meningioma development and growth. This has led to increasing pressure on healthcare professionals to understand the risk profile of different hormonal compounds with regards to meningioma incidence and growth. This is particularly relevant when managing patients with pre-existing meningioma tumours or with one or more risk factors for meningioma formation. The aim of this review was to summarise existing evidence from clinical studies (cohort and case–control) concerning the risk of meningioma associated with different types of exogenous hormones and the associated meningioma characteristics. The literature review identified over 30 cohort and case–control studies published between 2003 and 2026. Studies demonstrated a mixed risk profile of broadly defined hormonal replacement therapy and hormonal contraceptives; however, many of these studies did not capture specific information about duration, dose or medication type. Risk associated with synthetic progestin-containing compounds such as depot medroxyprogesterone and desogestrel contraceptives was higher and related to duration of use. Highly potent synthetic progestins including cyproterone acetate (CPA) carried the strongest risk profile and showed a strong association with multiple meningiomas and anterior/middle skull base location. In conclusion, there is strong evidence for a link between meningioma incidence and highly potent synthetic progestins such as CPA, but further evidence is needed regarding menopausal hormone therapy and broadly defined oral contraceptives, as well as the doses and durations that are associated with clinically relevant risk. There is a space for translational research in this area to better understand the molecular basis underlying the relationship between hormones and meningioma growth.
- 15 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5560
Open AccessExogenous Hormones and Their Clinical Implications for the Development and Growth of Meningioma Tumours
Meningiomas are the most common central nervous system tumour and are associated with significant morbidity. Mounting evidence implicates the role of exogenous hormones in meningioma development and growth. This has led to increasing pressure on healthcare professionals to understand the risk profile of different hormonal compounds with regards to meningioma incidence and growth. This is particularly relevant when managing patients with pre-existing meningioma tumours or with one or more risk factors for meningioma formation. The aim of this review was to summarise existing evidence from clinical studies (cohort and case–control) concerning the risk of meningioma associated with different types of exogenous hormones and the associated meningioma characteristics. The literature review identified over 30 cohort and case–control studies published between 2003 and 2026. Studies demonstrated a mixed risk profile of broadly defined hormonal replacement therapy and hormonal contraceptives; however, many of these studies did not capture specific information about duration, dose or medication type. Risk associated with synthetic progestin-containing compounds such as depot medroxyprogesterone and desogestrel contraceptives was higher and related to duration of use. Highly potent synthetic progestins including cyproterone acetate (CPA) carried the strongest risk profile and showed a strong association with multiple meningiomas and anterior/middle skull base location. In conclusion, there is strong evidence for a link between meningioma incidence and highly potent synthetic progestins such as CPA, but further evidence is needed regarding menopausal hormone therapy and broadly defined oral contraceptives, as well as the doses and durations that are associated with clinically relevant risk. There is a space for translational research in this area to better understand the molecular basis underlying the relationship between hormones and meningioma growth.
- Open Access
- 3 October 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 414
First reported case of Capnocytophaga canimorsus pituitary abscess
Background: Capnocytophaga canimorsus is a rare human pathogen, typically associated with exposure to dog saliva. It is a slow-growing, Gram-negative anaerobe, with clinical manifestations being sepsis, meningitis, or endocarditis. Pituitary abscesses are themselves uncommon, accounting for C. canimorsus, highlighting the diagnostic value of 16S ribosomal RNA (rRNA) polymerase chain reaction (PCR) when conventional microbiological methods are inconclusive. Case Description: A 69-year-old woman presented following a collapse with symptoms including hypernatremia, new-onset atrial fibrillation, and thyrotoxicosis. Initial sepsis workup–including cerebrospinal fluid analysis–suggested possible encephalitis. Brain magnetic resonance imaging revealed a cystic, contrast-enhancing pituitary lesion with central diffusion restriction. The patient underwent endoscopic transsphenoidal surgery, with intraoperative findings consistent with abscess formation. Despite direct culture yielding no growth, 16S rRNA PCR of the aspirated fluid identified C. canimorsus. Histology revealed xanthogranulomatous inflammation. The patient was treated with a 6-week course of intravenous ceftriaxone, with subsequent clinical and radiological recovery. Importantly, she had no known exposure to animal bites or saliva and no underlying immunosuppressive condition. Conclusion: This case is the first to implicate C. canimorsus in the formation of a pituitary abscess, expanding the spectrum of its potential clinical presentations. It underscores the diagnostic limitations of conventional microbiological techniques in deep-seated intracranial infections and supports the role of 16S rRNA PCR as a critical adjunct when routine cultures are negative. Clinicians should maintain a high index of suspicion for atypical pathogens in sellar lesions and consider molecular diagnostics early, particularly when histopathology reveals inflammatory features suggestive of infection without an identifiable organism.
- 3 October 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 414
Open AccessFirst reported case of Capnocytophaga canimorsus pituitary abscess
Background: Capnocytophaga canimorsus is a rare human pathogen, typically associated with exposure to dog saliva. It is a slow-growing, Gram-negative anaerobe, with clinical manifestations being sepsis, meningitis, or endocarditis. Pituitary abscesses are themselves uncommon, accounting for C. canimorsus, highlighting the diagnostic value of 16S ribosomal RNA (rRNA) polymerase chain reaction (PCR) when conventional microbiological methods are inconclusive. Case Description: A 69-year-old woman presented following a collapse with symptoms including hypernatremia, new-onset atrial fibrillation, and thyrotoxicosis. Initial sepsis workup–including cerebrospinal fluid analysis–suggested possible encephalitis. Brain magnetic resonance imaging revealed a cystic, contrast-enhancing pituitary lesion with central diffusion restriction. The patient underwent endoscopic transsphenoidal surgery, with intraoperative findings consistent with abscess formation. Despite direct culture yielding no growth, 16S rRNA PCR of the aspirated fluid identified C. canimorsus. Histology revealed xanthogranulomatous inflammation. The patient was treated with a 6-week course of intravenous ceftriaxone, with subsequent clinical and radiological recovery. Importantly, she had no known exposure to animal bites or saliva and no underlying immunosuppressive condition. Conclusion: This case is the first to implicate C. canimorsus in the formation of a pituitary abscess, expanding the spectrum of its potential clinical presentations. It underscores the diagnostic limitations of conventional microbiological techniques in deep-seated intracranial infections and supports the role of 16S rRNA PCR as a critical adjunct when routine cultures are negative. Clinicians should maintain a high index of suspicion for atypical pathogens in sellar lesions and consider molecular diagnostics early, particularly when histopathology reveals inflammatory features suggestive of infection without an identifiable organism.
- Open Access
- 31 January 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 24
Early use of targeted blood patch in spontaneous intracranial hypotension presenting with bilateral subdural hematomas and acute infarcts
Background: Spontaneous intracranial hypotension (SIH) is a rare but important condition characterized by cerebrospinal fluid (CSF) leakage, typically presenting with postural headaches. In severe cases, SIH can result in subdural hematomas (SDHs), brain herniation, and acute infarcts. The 2023 SIH guidelines recommend starting with nontargeted epidural blood patches as the initial treatment, with up to two attempts before considering a targeted patch. Nontargeted patches are effective in most cases by distributing blood widely in the epidural space. However, in rapidly deteriorating patients, targeted blood patches may be necessary, especially when a specific leak site has been identified. This report highlights the importance of timely, targeted interventions in severe SIH cases. Case Description: A 34-year-old male presented with a 6-month history of worsening headaches, impaired mobility, and stupor. On admission, his Glasgow Coma Scale was 12, which rapidly deteriorated to 5. Imaging revealed bilateral chronic SDHs, cerebellar tonsillar herniation, and signs of intracranial hypotension despite no history of trauma or anticoagulant use. Initial surgical evacuation of the hematomas failed to improve the patient’s neurological status. Subsequent magnetic resonance imaging and computed tomography myelogram identified a CSF leak at the T12 level. Given the patient’s critical state and rapid neurological decline, we opted for a targeted epidural blood patch at the L1/2 level. This intervention led to significant clinical improvement, with follow-up imaging demonstrating a reduction in the subdural collections and resolution of the leak. The patient fully recovered and remained asymptomatic at a 6-month follow-up. Conclusion: This case highlights the need for flexibility in SIH management, particularly in severe cases with acute neurological decline. While nontargeted blood patches are typically recommended, early use of a targeted patch when imaging identifies the leak can lead to faster resolution and improved outcomes. Personalized treatment strategies are essential for managing complex SIH presentations and preventing further neurological complications.
- 31 January 2025
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 16, 24
Open AccessEarly use of targeted blood patch in spontaneous intracranial hypotension presenting with bilateral subdural hematomas and acute infarcts
Background: Spontaneous intracranial hypotension (SIH) is a rare but important condition characterized by cerebrospinal fluid (CSF) leakage, typically presenting with postural headaches. In severe cases, SIH can result in subdural hematomas (SDHs), brain herniation, and acute infarcts. The 2023 SIH guidelines recommend starting with nontargeted epidural blood patches as the initial treatment, with up to two attempts before considering a targeted patch. Nontargeted patches are effective in most cases by distributing blood widely in the epidural space. However, in rapidly deteriorating patients, targeted blood patches may be necessary, especially when a specific leak site has been identified. This report highlights the importance of timely, targeted interventions in severe SIH cases. Case Description: A 34-year-old male presented with a 6-month history of worsening headaches, impaired mobility, and stupor. On admission, his Glasgow Coma Scale was 12, which rapidly deteriorated to 5. Imaging revealed bilateral chronic SDHs, cerebellar tonsillar herniation, and signs of intracranial hypotension despite no history of trauma or anticoagulant use. Initial surgical evacuation of the hematomas failed to improve the patient’s neurological status. Subsequent magnetic resonance imaging and computed tomography myelogram identified a CSF leak at the T12 level. Given the patient’s critical state and rapid neurological decline, we opted for a targeted epidural blood patch at the L1/2 level. This intervention led to significant clinical improvement, with follow-up imaging demonstrating a reduction in the subdural collections and resolution of the leak. The patient fully recovered and remained asymptomatic at a 6-month follow-up. Conclusion: This case highlights the need for flexibility in SIH management, particularly in severe cases with acute neurological decline. While nontargeted blood patches are typically recommended, early use of a targeted patch when imaging identifies the leak can lead to faster resolution and improved outcomes. Personalized treatment strategies are essential for managing complex SIH presentations and preventing further neurological complications.
- 12 January 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-11
To assess the safety of laparoscopy in patients with CSF catheters draining distally into the abdomen
Purpose This study evaluates the safety of laparoscopic procedures in patients with cerebrospinal fluid (CSF) catheters draining distally into the abdomen. Methods A systematic search across PubMed, Scopus, and Ovid databases using pertinent keywords yielded 47 relevant papers, encompassing 197 cases, for analysis. Results In the pediatric cohort (n = 129), male (49.6%) and female (34.1%) cases were reported, while gender remained unspecified in 16.3%. Shunt indications included unspecified (126 cases) and Meningomyelocele (3 cases). Laparoscopic procedures encompassed gastric (72.1%), urologic (21.7%), and other (6.2%) indications. Peri-operative shunt management included subcostal incision and clamping (1), ICP monitoring and drainage (2), and distal shunt flow confirmation (1). The prevalent complication was mechanical obstruction (10.1%), followed by pseudocyst formation (1.5%) and infection (2.3%). In the adult cohort (n = 61), males (60.6%) and females (39.3%) with a median age of 55 years were observed. Management strategies encompassed sponge packing and mobilization (11), distal shunt flow confirmation (2), shunt clamping (3), Transcranial Doppler monitoring (2), and no manipulation (30). Shunt infection emerged as the primary complication (2). Overall, 24 patients encountered VP shunt-related complications post-laparoscopy. Conclusion This study underscores the safety of laparoscopic interventions in patients with ventriculoperitoneal or lumboperitoneal shunts when facilitated by interdisciplinary cooperation. A meticulous preoperative assessment for shunt track localization, intraoperative visualization of shunt tip with CSF flow, vigilant perioperative anesthetic monitoring, and shunt dysfunction surveillance are crucial for favorable outcomes in laparoscopic procedures for these patients.
- 12 January 2024
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 166 (1) , 1-11
To assess the safety of laparoscopy in patients with CSF catheters draining distally into the abdomen
Purpose This study evaluates the safety of laparoscopic procedures in patients with cerebrospinal fluid (CSF) catheters draining distally into the abdomen. Methods A systematic search across PubMed, Scopus, and Ovid databases using pertinent keywords yielded 47 relevant papers, encompassing 197 cases, for analysis. Results In the pediatric cohort (n = 129), male (49.6%) and female (34.1%) cases were reported, while gender remained unspecified in 16.3%. Shunt indications included unspecified (126 cases) and Meningomyelocele (3 cases). Laparoscopic procedures encompassed gastric (72.1%), urologic (21.7%), and other (6.2%) indications. Peri-operative shunt management included subcostal incision and clamping (1), ICP monitoring and drainage (2), and distal shunt flow confirmation (1). The prevalent complication was mechanical obstruction (10.1%), followed by pseudocyst formation (1.5%) and infection (2.3%). In the adult cohort (n = 61), males (60.6%) and females (39.3%) with a median age of 55 years were observed. Management strategies encompassed sponge packing and mobilization (11), distal shunt flow confirmation (2), shunt clamping (3), Transcranial Doppler monitoring (2), and no manipulation (30). Shunt infection emerged as the primary complication (2). Overall, 24 patients encountered VP shunt-related complications post-laparoscopy. Conclusion This study underscores the safety of laparoscopic interventions in patients with ventriculoperitoneal or lumboperitoneal shunts when facilitated by interdisciplinary cooperation. A meticulous preoperative assessment for shunt track localization, intraoperative visualization of shunt tip with CSF flow, vigilant perioperative anesthetic monitoring, and shunt dysfunction surveillance are crucial for favorable outcomes in laparoscopic procedures for these patients.
- 27 July 2021
- Published by Springer Nature
- p. 161-168
Non-functioning Pituitary Adenoma
- 27 July 2021
- Published by Springer Nature
- p. 179-186
Anterior Skull Base Meningioma
- 21 August 2020
- Published by Bioscientifica in Endocrine Abstracts
The role of the tumour microenvironment in pituitary adenoma angiogenesis
Introduction: Angiogenesis is regulated by different components of the tumour microenvironment (TME) including cytokines and immune cells. Although angiogenesis has been studied in pituitary adenomas (PAs), the role of individual TME components in PA angiogenesis remains largely unknown. We aimed to characterise the role of the TME components in determining the angiogenesis of PAs, focusing on PA-infiltrating immune cells and the PA-derived cytokine network. Methods: Different immune cells were studied by immunohistochemistry in 24 human PAs (16 non-functioning PAs (NFPAs) and 8 somatotrophinomas): macrophages (CD68), M2-macrophages (CD163), M1-macrophages (HLA-DR), cytotoxic T lymphocytes (CD8), T helper lymphocytes (CD4), T regulatory cells (FOXP3), B cells (CD20) and neutrophils (neutrophil elastase); endothelial cells were assessed with CD31. Five normal pituitary samples (NP) were included for comparison. Microvessel density and vascular morphological parameters were estimated with ImageJ software. Cytokine secretome from these same 24 human PAs were assessed on primary cell culture supernatants using a multiplex immunoassay panel with 42 cytokines. Results: PAs contained 4× more CD68 + macrophages than NP, with a 3-fold increased M2:M1 macrophage ratio, as well as more CD4 + T cells but fewer CD8 + T cells or neutrophils. Microvessel density and microvessel area were higher in NP than PAs, which also had more round and regular vessels. NFPAs had vessels of increased caliber (higher perimeter and Feret’s diameter), occupying an increased area comparing to somatotrophinomas. PAs with more macrophages tended to have higher microvessel density and area, as well as a higher perimeter and Feret’s diameter. The M2:M1 macrophage ratio correlated with microvessel density (P = 0.015) and microvessel area (P < 0.001) in PAs. PAs with more CD4 + T cells had higher microvessel area (P = 0.035), while PAs with more FOXP3 + cells were associated with lower microvessel density (P = 0.021). PAs with more B cells had more rounded vessels (P = 0.021). Of the studied PA-derived cytokines and growth factors, only FGF-2 and CXCL10 were significantly associated with microvessel architecture, namely vessel perimeter (r = –0.407; P = 0.048) and area occupied per vessel (r = 0.407; P = 0.049), respectively. Conclusions: Our data suggest that different TME components may influence the angiogenesis of PAs: M2-macrophages appears to play a relevant role in PA angiogenesis, and B, CD4 + and FOXP3 + lymphocytes may also have a modulatory role in the PA neovascularisation.
- 21 August 2020
- Published by Bioscientifica in Endocrine Abstracts
The role of the tumour microenvironment in pituitary adenoma angiogenesis
Introduction: Angiogenesis is regulated by different components of the tumour microenvironment (TME) including cytokines and immune cells. Although angiogenesis has been studied in pituitary adenomas (PAs), the role of individual TME components in PA angiogenesis remains largely unknown. We aimed to characterise the role of the TME components in determining the angiogenesis of PAs, focusing on PA-infiltrating immune cells and the PA-derived cytokine network. Methods: Different immune cells were studied by immunohistochemistry in 24 human PAs (16 non-functioning PAs (NFPAs) and 8 somatotrophinomas): macrophages (CD68), M2-macrophages (CD163), M1-macrophages (HLA-DR), cytotoxic T lymphocytes (CD8), T helper lymphocytes (CD4), T regulatory cells (FOXP3), B cells (CD20) and neutrophils (neutrophil elastase); endothelial cells were assessed with CD31. Five normal pituitary samples (NP) were included for comparison. Microvessel density and vascular morphological parameters were estimated with ImageJ software. Cytokine secretome from these same 24 human PAs were assessed on primary cell culture supernatants using a multiplex immunoassay panel with 42 cytokines. Results: PAs contained 4× more CD68 + macrophages than NP, with a 3-fold increased M2:M1 macrophage ratio, as well as more CD4 + T cells but fewer CD8 + T cells or neutrophils. Microvessel density and microvessel area were higher in NP than PAs, which also had more round and regular vessels. NFPAs had vessels of increased caliber (higher perimeter and Feret’s diameter), occupying an increased area comparing to somatotrophinomas. PAs with more macrophages tended to have higher microvessel density and area, as well as a higher perimeter and Feret’s diameter. The M2:M1 macrophage ratio correlated with microvessel density (P = 0.015) and microvessel area (P < 0.001) in PAs. PAs with more CD4 + T cells had higher microvessel area (P = 0.035), while PAs with more FOXP3 + cells were associated with lower microvessel density (P = 0.021). PAs with more B cells had more rounded vessels (P = 0.021). Of the studied PA-derived cytokines and growth factors, only FGF-2 and CXCL10 were significantly associated with microvessel architecture, namely vessel perimeter (r = –0.407; P = 0.048) and area occupied per vessel (r = 0.407; P = 0.049), respectively. Conclusions: Our data suggest that different TME components may influence the angiogenesis of PAs: M2-macrophages appears to play a relevant role in PA angiogenesis, and B, CD4 + and FOXP3 + lymphocytes may also have a modulatory role in the PA neovascularisation.